HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Po-Li Wei Selected Research

ovatodiolide

1/2020Preclinical investigation of ovatodiolide as a potential inhibitor of colon cancer stem cells via downregulating sphere-derived exosomal β-catenin/STAT3/miR-1246 cargoes.
1/2020Erratum: Preclinical investigation of ovatodiolide as a potential inhibitor of colon cancer stem cells via downregulating sphere-derived exosomal β-catenin/STAT3/miR-1246 cargoes.
1/2017Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Po-Li Wei Research Topics

Disease

61Neoplasms (Cancer)
02/2022 - 11/2003
26Neoplasm Metastasis (Metastasis)
02/2022 - 06/2009
19Colonic Neoplasms (Colon Cancer)
06/2020 - 06/2009
17Hepatocellular Carcinoma (Hepatoma)
01/2021 - 05/2009
12Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 01/2016
8Carcinogenesis
02/2022 - 09/2010
8Breast Neoplasms (Breast Cancer)
02/2018 - 09/2010
6Rectal Neoplasms (Rectal Cancer)
02/2021 - 05/2012
5Stomach Neoplasms (Stomach Cancer)
07/2016 - 09/2011
5Appendicitis
06/2014 - 04/2004
5Morbid Obesity
11/2006 - 12/2002
3Wounds and Injuries (Trauma)
10/2018 - 06/2004
3Pain (Aches)
09/2018 - 09/2003
3Weight Loss (Weight Reduction)
05/2005 - 12/2003
2Infections
01/2022 - 06/2013
2Inflammation (Inflammations)
01/2019 - 01/2014
2Hyperlipidemias (Hyperlipidemia)
09/2018 - 12/2003
2Carcinoma (Carcinomatosis)
03/2015 - 04/2006
2Hernia (Hernias)
11/2010 - 07/2006
2Liver Neoplasms (Liver Cancer)
05/2009 - 05/2009
1Sarcoma (Soft Tissue Sarcoma)
02/2022
1Lung Injury
01/2022
1COVID-19
01/2022
1Actinic Keratosis
01/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Critical Illness (Critically Ill)
01/2022
1Thyroid Neoplasms (Thyroid Cancer)
09/2021

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2010
10Small Interfering RNA (siRNA)IBA
03/2015 - 06/2009
9Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2014
9Endoplasmic Reticulum Chaperone BiPIBA
06/2015 - 02/2010
8Glucose (Dextrose)FDA LinkGeneric
06/2015 - 02/2010
7MicroRNAs (MicroRNA)IBA
03/2021 - 10/2013
7NicotineFDA Link
07/2016 - 09/2010
6CateninsIBA
02/2022 - 01/2017
6VimentinIBA
01/2019 - 01/2012
6Cholinergic ReceptorsIBA
07/2016 - 06/2009
6Messenger RNA (mRNA)IBA
01/2016 - 05/2009
5Pharmaceutical PreparationsIBA
01/2022 - 02/2010
5glucose-regulated proteinsIBA
01/2021 - 04/2016
5CurcuminIBA
09/2018 - 08/2011
4Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2022 - 01/2016
4Fluorouracil (Carac)FDA LinkGeneric
06/2020 - 01/2017
4SurvivinIBA
10/2014 - 01/2012
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
07/2012 - 09/2010
3Interleukin-6 (Interleukin 6)IBA
06/2020 - 01/2017
3InterleukinsIBA
06/2020 - 03/2015
3ovatodiolideIBA
01/2020 - 01/2017
3ThrombomodulinIBA
01/2016 - 01/2014
3Fibronectins (Fibronectin)IBA
01/2016 - 06/2011
3Cadherins (E-Cadherin)IBA
03/2015 - 06/2009
3CarcinogensIBA
07/2012 - 06/2009
3alpha7 Nicotinic Acetylcholine ReceptorIBA
07/2012 - 06/2009
2Cetuximab (Erbitux)FDA Link
02/2022 - 01/2016
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2022 - 03/2015
2ErbB Receptors (EGF Receptor)IBA
02/2022 - 06/2020
2Epidermal Growth Factor (EGF)IBA
01/2022 - 03/2021
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020 - 08/2017
2Drug CombinationsIBA
01/2019 - 01/2017
2HSP27 Heat-Shock ProteinsIBA
12/2018 - 09/2018
2CytokinesIBA
09/2018 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 11/2013
2Estrogen ReceptorsIBA
02/2018 - 09/2011
2Bevacizumab (Avastin)FDA Link
01/2018 - 12/2012
2Thyroid HormonesIBA
01/2018 - 01/2016
2IntegrinsIBA
01/2018 - 01/2016
2Hormones (Hormone)IBA
06/2014 - 03/2011
24- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
07/2012 - 06/2009
2Estrogens (Estrogen)FDA Link
09/2011 - 03/2011
2DNA (Deoxyribonucleic Acid)IBA
06/2011 - 06/2009
1Matrix Metalloproteinases (MMPs)IBA
02/2022
1Sulfasalazine (Azulfidine)FDA LinkGeneric
02/2022
1C-Reactive ProteinIBA
01/2022
1S100 Calcium-Binding Protein A4IBA
01/2022
1DefensinsIBA
01/2022
1SolutionsIBA
01/2022
1Aldehyde DehydrogenaseIBA
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022
13-ingenyl angelateIBA
01/2022
1Ferritins (Ferritin)IBA
01/2022
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2021

Therapy/Procedure

20Therapeutics
02/2022 - 05/2012
9Drug Therapy (Chemotherapy)
01/2019 - 04/2004
5Appendectomy
06/2014 - 04/2004
4Length of Stay
03/2011 - 09/2003
4Gastric Bypass (Roux-en-Y Gastric Bypass)
07/2006 - 05/2005
3Bariatric Surgery
07/2006 - 12/2003
2Radiotherapy
02/2021 - 08/2020
2Chemoradiotherapy
01/2020 - 09/2016
2Laparotomy
06/2019 - 04/2006
2Neoadjuvant Therapy
10/2017 - 05/2012
2Colectomy
08/2015 - 04/2004
2Herniorrhaphy
10/2012 - 07/2006
2Operative Surgical Procedures
11/2010 - 05/2009
2Lasers (Laser)
09/2010 - 05/2009
2Surgical Instruments (Clip)
07/2006 - 06/2004
1Intravenous Infusions
01/2022
1Immunotherapy
01/2022
1Precision Medicine
01/2022